Iron is vital for cells, because it catalyzes key enzyme reactions; it is also crucial for respiration, fixing atmospheric oxygen to hemoglobin in red blood cells. Iron deficiency can lead to severe anemia, with inadequate tissue oxygenation. An excess of iron is also toxic, as it facilitates the generation of free radicals that can attack the liver, heart and pancreas. This is the case in hereditary hemochromatosis, a genetic disorder which, in 80% of cases, is linked to a point mutation in the Hfe-1 gene, leading to excessive iron uptake by the intestinal tract. Hereditary hemochromatosis is very frequent in western countries, affecting one in 300 people. The body has no physiological mechanism for eliminating iron, and the only effective treatment for patients with hereditary hemochromatosis is bleeding, in some cases several times a week. These patients, and their doctors, are eagerly awaiting a breakthrough in our understanding of the mechanisms regulating iron metabolism, that might have therapeutic implications.
Dietary iron enters the body via cells known as enterocytes, that line the intestinal folds. Humoral signals are known to modulate how much iron these cells take up, according to the body`s internal stores. Yet, despite intense research over the last four decades, no-one had previously been able to identify these signals.
It is by chance that Gaël Nicolas, Sophie Vaulont and their coworkers came across such a signal while working on knock-out mice developed in their laboratory. The mice lacked a transcription factor known as USF2 (upstream stimulatory factor 2), thought to be involved in glucose metabolism. To their surprise, the team found that the mice had disorders similar to those of patients with hereditary hemochromatosis, namely premature ageing of the pancreas and liver, which take on an abnormal brown color - a sign of iron accumulation. Further tests indeed showed that the animals had a form of hemochromatosis. Intrigued, the team created a subtractive RNA bank in order to determine whether any other genes were abnormally expressed in their model. This was effectively the case. One abnormally expressed gene was found to correspond to a recently identified sequence of 25 amino acids found in members of an antimicrobial peptide family called the defensins. The peptide in question - hepcidin - is produced by the liver and secreted into the bloodstream. Hepcidin has a degree of antimicrobial activity, but Axel Kahn, Sophie Vaulont and their colleagues at Bichat Hospital in Paris believe that it acts essentially as a true hormone, inhibiting iron uptake by intestinal cells; they also believe that when hepcidin dysfunctions the body has no way of limiting iron absorption into the bloodstream.
Nathalie Christophe | alphagalileo
‘Farming’ bacteria to boost growth in the oceans
24.10.2016 | Max-Planck-Institut für marine Mikrobiologie
Calcium Induces Chronic Lung Infections
24.10.2016 | Universität Basel
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences
24.10.2016 | Physics and Astronomy